https://www.selleckchem.com/pr....oducts/protac-tubuli
The wounds were not only failed to close but they became broader in Her-2 cells treated with targeted liposomes of siRNA. Consequently, the amount of FASN decreased by 80% in SK-BR3 cells treated with non-targeted liposomes and it was 30% and 60% in the MCF-7 cells treated with DSPC/Chol and DOPE/CHEMS liposomes, respectively. In this study, we developed the formulation that targeted Her-2 for the suppression of FASN and, therefore, inhibited the proliferation of breast cancer cells. In this study, we developed the for
Like
Comment
Share
